Yonsei University · 医学
Professor Yoo Jin Hong's research lab specializes in advanced medical imaging technologies, focusing on the application of dual-energy CT and cardiac MRI to improve the diagnosis and risk stratification of cardiovascular diseases. The lab investigates functional and structural tissue characterization in conditions such as pulmonary thromboembolism and chemotherapy-induced cardiotoxicity, with an emphasis on early detection and non-invasive monitoring. Key research directions include quantitative tissue mapping using T1-mapping and volumetric analysis for differentiating cardiac masses like tumors and thrombi.
Figures are computed from collected data and may differ slightly.
Chronic PTE segments were significantly more enhanced on the delayed phase of two-phase dual-energy CT images than were acute PTE segments, possibly resulting from more extensive systemic collateral formation in chronic PTE. Two-phase dual-energy CT can be used to differentiate distinct regional perfusion patterns between acute and chronic PTE.
A reliable, non-invasive diagnostic method is needed for early detection and serial monitoring of cardiotoxicity, a well-known side effect of chemotherapy. This study aimed to assess the feasibility of T1-mapping cardiac magnetic resonance imaging (CMR) for evaluating subclinical myocardial changes in a doxorubicin-induced cardiotoxicity rabbit model. Adult male New Zealand White rabbits were injected twice-weekly with doxorubicin and subjected to CMR on a clinical 3T MR system before and every
Pulmonary embolism (PE) is a potentially fatal disease if the diagnosis or treatment is delayed. Currently, multidetector computed tomography (MDCT) is considered the standard imaging method for diagnosing PE. Dual-energy CT (DECT) has the advantages of MDCT and can provide functional information for patients with PE. The aim of this review is to present the potential clinical applications of DECT in PE, focusing on the diagnosis and risk stratification of PE.
It is critical to distinguish between cardiac tumors and thrombi because they require different treatment strategies. Although accurate differentiation of these cardiac masses can be challenging, computed tomography (CT) and magnetic resonance imaging (MRI) are promising tools to improve their diagnosis. This study aimed to assess the diagnostic value of a volume-based quantification strategy using dual-energy CT to differentiate between cardiac tumors and thrombi. We prospectively enrolled 41 p
Five control rats and 36 doxorubicin-treated rats were included and classified into treatment periods. In the doxorubicin-treated rats, the LVEF significantly decreased after 12 weeks of treatment (control vs. 12-week treated: 73 ± 4% vs. 59 ± 9%, P = 0.01). Increased native T1 and ECV were observed after 6 weeks of treatment (control vs. 6-week treated: 1148 ± 58 ms, 14.3 ± 1% vs. 1320 ± 56 ms, 20.3 ± 3%; P = 0.005, < 0.05, respectively). T2 values also increased by six weeks of treatment (cont
Open papers in the app to read, cite, and organize with AI.
